Miura Jun, Honma Ken-Ichi, Honma Sato
Sapporo Hanazono Hospital, 1-30 South 15 West 15, Chuo-ku, Sapporo, 0640915 Japan.
Faculty of Pharmaceutical Sciences, Hokkaido University of Science, Sapporo, Japan.
Sleep Biol Rhythms. 2022 Jan 19;20(2):315-317. doi: 10.1007/s41105-021-00364-3. eCollection 2022 Apr.
We report two cases who had been diagnosed with major depression, but found to have periodic limb movement disorder (PLMD) or restless legs syndrome (RLS) as major disorder. Both patients had difficulties in occupational and/or daily lives. In neither case, antidepressants were effective in symptom remission. In contrast, rotigotine transdermal patch was effective not only for core symptoms of PLMD or RLS but also for accompanying depressive symptoms. Since PLMD and RLS are associated with dopaminergic dysfunction etiologically, a dopamine receptor agonist rotigotine might be a good choice for patients with PLMD or RLS accompanying depression.
我们报告了两例最初被诊断为重度抑郁症,但后来发现主要疾病是周期性肢体运动障碍(PLMD)或不宁腿综合征(RLS)的病例。两名患者在职业和/或日常生活中都存在困难。在这两例中,抗抑郁药均未能有效缓解症状。相比之下,罗替戈汀透皮贴剂不仅对PLMD或RLS的核心症状有效,对伴随的抑郁症状也有效。由于PLMD和RLS在病因上与多巴胺能功能障碍有关,多巴胺受体激动剂罗替戈汀可能是PLMD或RLS伴发抑郁症患者的理想选择。